FR940405-1-00063 FR940405-1-00013 Table III&hyph;6._ Vapor Phase Constituents of Tobacco Smoke and Related Health Effects 1Constituent 1Amount in MS 1Ratio in SS/MS 1Health effects Carbon monoxide 10&hyph;23 mg 2.5&hyph;4.7 Nervous system, cardiovascular system.1 Carbon dioxide 20&hyph;40 mg 8&hyph;11 Nervous system, cardiovascular system.1 Carbonyl sulfide 12&hyph;42 μg 0.03&hyph;0.13 Irritant, cardiovascular, and nervous systems.1 Benzene 12&hyph;48 μg 5&hyph;10 Known human3 carcinogen. Toluene 100&hyph;200 μg 5.6&hyph;8.3 Irritant, nervous system.1 Formaldehyde 70&hyph;100 μg 0.1&hyph; ¢ 50 Probable human carcinogen.3 Acrolein 60&hyph;100 μg 8&hyph;15 Irritant, pulmonary.1 Acetone 100&hyph;250 μg 2&hyph;5 Irritant.1 Pyridine 16&hyph;40 μg 6.5&hyph;20 Irritant, nervous system, liver, kidney.1 3-methylpyridine 12&hyph;36 μg 3&hyph;13 Irritant.2 3-vinylpyridine 11&hyph;30 μg 20&hyph;40 Irritant.2 Hydrogen cyanide 400&hyph;500 μg 0.1&hyph;0.25 Irritant, nervous, cardiovascular and pulmonary system.1 Hydrazine 32 ng 3 Probable human carcinogen.3 Ammonia 50&hyph;130 μg 3.7&hyph;5.1 Irritant.1 Methylamine 11.5&hyph;28.7 μg 4.2&hyph;6.4 Irritant.1 Dimethylamine 7.8&hyph;10 μg 3.7&hyph;5.1 Irritant1. Nitrogen oxides 100&hyph;600 μg 4&hyph;10 Pulmonary and cardiovascular system.1 N-nitrosodimenthylamine 10&hyph;40 ng 20&hyph;100 Probable human carcinogen.3 N-nitrodiethylamine ND&hyph;25 ng <40 Probable human carcinogen.3 N-nitrosopyrrolidine 6&hyph;30 ng 6&hyph;30 Probable human carcinogen.3 Formic acid 210&hyph;490 μg 1.4&hyph;1.6 Irritant, skin, kidney, liver1. Acetic acid 330&hyph;810 μg 1.9&hyph;3.6 Irritant.1 Methyl chloride 150&hyph;600 μg 1.7&hyph;3.3 Nervous system.1 1,3-butadiene 69.2 μg 3&hyph;6 Probable human carcinogen.3 1NIOSH Pocket Guide to Chemical Hazards. U.S. Department of Health and Human Services. Public Health Services, 1990. Ex. 4&hyph;238. 2Hazards in the Chemical Laboratory. Ed: L. Bretherick, The Royal Society of Chemistry, 1986. [Ex. 4&hyph;137] 3EPA: Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders, 1992. [Ex. 4&hyph;311]
